Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 GeneticVariation disease UNIPROT Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. 16885549 2006
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 Biomarker disease MGD Sur1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion. 10734066 2000
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 Biomarker disease GENOMICS_ENGLAND
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 Biomarker disease GENOMICS_ENGLAND
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 GeneticVariation disease CLINVAR
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 Biomarker disease CTD_human
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 CausalMutation disease CLINVAR
DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)
0.900 Biomarker disease GENOMICS_ENGLAND
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 Biomarker disease BEFREE Many patients who have PNDM have been successfully treated with sulphonylureas, a common class of antidiabetic drugs that bind to SUR1 and indirectly inhibit Kir6.2, thereby promoting insulin secretion. 29844136 2018
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE We report the successful transition from insulin to SU in two Iraqi siblings with PNDM due to ABCC8 mutation, one with iDEND. 27849623 2016
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Mutations in KATP channel genes (KCNJ11, ABCC8) and the insulin gene (INS) are the most common causes of PNDM. 23050777 2013
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GermlineCausalMutation disease ORPHANET We identified the Pro1198Leu ABCC8 mutation in a PNDM patient, and clarified the functional and clinical characterization. 24843665 2013
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation. 22306677 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Mutations in the KCNJ11 and ABCC8 genes that encode the pancreatic K(ATP) channel are the commonest cause of permanent neonatal diabetes mellitus (PNDM). 22859427 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Permanent neonatal diabetes mellitus (PNDM) in European population has an incidence of at least 1 in 260 000 live births and is most commonly due to mutations in KCNJ11 and ABCC8. 22060631 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Here, we report the long-term follow-up results of two siblings with PNDM who were treated with insulin until ABCC8 gene mutation was identified, and were successfully transferred to oral SU therapy. 22672870 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GermlineCausalMutation disease ORPHANET The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. 22498247 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Activating mutations of the ABCC8 gene can lead to permanent neonatal diabetes mellitus (PNDM). 22768668 2012
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GermlineCausalMutation disease ORPHANET Review on monogenic diabetes. 21844708 2011
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Although PNDM is a rare phenomenon (one case in about 200,000 live births), this discovery has had a large impact on clinical practice as most carriers of KCNJ11 and ABCC8 gene mutations have been switched from insulin to oral sulphonylureas with an improvement in glycemic control. 21054355 2011
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Mutations in KCNJ11, ABCC8, or INS are the cause of permanent neonatal diabetes mellitus in about 50%-60% of the patients. 21823539 2011
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 Biomarker disease BEFREE Activating mutations in genes encoding the Kir6.2 (KCNJ11) and SUR1 (ABCC8) subunits of the pancreatic ATP-sensitive K(+) channel are a common cause of permanent neonatal diabetes (PNDM). 19351728 2009
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 Biomarker disease BEFREE Molecular analysis of chromosome 6 anomalies and the KCNJ11 and ABCC8 genes encoding Kir6.2 and SUR1 provides a tool for distinguishing transient from permanent neonatal diabetes mellitus in the neonatal period. 18279778 2008
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Mutations in KCNJ11, ABCC8, or INS are the cause of permanent neonatal diabetes mellitus in about 50% of patients diagnosed with diabetes before 6 months of age and in a small fraction of those diagnosed between 6 and 12 months. 18662362 2008
DIABETES MELLITUS, PERMANENT NEONATAL
0.800 GeneticVariation disease BEFREE Some other forms of monogenic diabetes associated with impaired function of the beta-cell, such as MODY3 and PNDM linked to mutations in Kir6.2 and SUR1 genes, can be successfully managed by sulphonylurea agents. 17488343 2008